From: Role of blood glucose and fat profile in lung function pattern of Indian type 2 diabetic subjects
| Characteristics | N | Diabetic subjects |
|---|---|---|
| Male | 465 | 268 (58) |
| Age, yrs.* | 465 | 54.58 (11.11) |
| BMI, kg/m2* | 462 | 26.71 (4.08) |
| Waist-Hip ratio* | 314 | 0.96 (0.10) |
| FVC, Liters* | 374 | 2.49 (0.52) |
| FEV1, Liters* | 374 | 2.02 (0.44) |
| % FEV1/FVC* | 374 | 82.03 (6.83) |
| % predicted FVC | 374 | 85.88 (13.53) |
| % predicted FEV1 | 374 | 85.87 (14.06) |
| Smoking | 465 | 34 (7.31) |
| Tobacco | 465 | 97 (21.00) |
| Alcohol | 462 | 76 (16.45) |
| Non-vegetarian* | 465 | 295 (63.00) |
| Chronic cough* | 465 | 51 (11.00) |
| Dyspnea(MRC1–5)* | 465 | 145 (31.00) |
| Wheezing* | 465 | 40 (8.60) |
| Tightness* | 465 | 39 (8.40) |
| Allergy symptom | 465 | 81 (17.40) |
| COPD history | 465 | |
| self* | 10 (2.40) | |
| family | 6 (1.50) | |
| Asthma history | 465 | |
| self* | 17 (4.20) | |
| family * | 66 (16.20) | |
| TZD | 465 | 38 (11.50) |
| Aspirin | 465 | 162 (48.00) |
| Statin | 465 | 190 (56.5) |